— Know what they know.
Not Investment Advice

CARM Smart Money

Carisma Therapeutics, Inc.
1W: -37.5% 1M: -28.6% 3M: -91.5% YTD: -98.9% 1Y: -99.8% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±41.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $20923 mcap · 30M float · 0.080% daily turnover · Short 39% of daily vol

🏦 Institutional Activity

Latest: Q2 2026
3
Institutions Holding
-4 vs prior
0.0%
Ownership
-228.95%
0 New
0 Increased
2 Reduced
2 Closed

👔 Insider Trades

4 records
Date Name Title Type Shares Price Value Filing
2025-10-07 Klichinsky Michael officer: chief scientific officer S-Sale 56,982 $0.25 $14K Filing
2025-10-03 Klichinsky Michael officer: chief scientific officer S-Sale 119,347 $0.26 $31K Filing
2025-10-02 Klichinsky Michael officer: chief scientific officer S-Sale 200,000 $0.25 $51K Filing
2025-10-01 Klichinsky Michael officer: chief scientific officer S-Sale 165,000 $0.26 $42K Filing

🏛️ Congressional Trades

0 records
Date Politician Chamber Type Amount Filing
No congressional trades found

🏦 Top Institutional Holders

3 holders
Holder Shares Value Date Reported Filing
Union Bancaire Privee, UBP SA 785 $0K — 2026-06-30 Filing
Merck & Co., Inc. 0 $0K -1,473,240 2026-06-30 Filing
Ascentis Independent Advisors 0 $0K -200 2026-06-30 Filing

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms